One Wales interim decisions (W)
- 09/01/22
- Rituximab for myasthenia gravis (OW12)
-
-
-
Dyddiad adolygu diwethaf: 29/12/2021
- 09/01/22
- Rituximab for interstitial lung disease (OW13)
-
-
-
Dyddiad adolygu diwethaf: 29/12/2021
- 09/01/22
- Abiraterone acetate (Zytiga®) for prostate cancer (OW17)
-
-
-
Dyddiad adolygu diwethaf: 16/07/2021
- 09/01/22
- Azacitidine for progressive angioimmunoblastic T-cell lymphoma (OW16)
-
-
-
Dyddiad adolygu diwethaf: 26/07/2021
- 09/01/22
- Rituximab for pemphigus and pemphigoid (OW10)
-
-
-
Dyddiad adolygu diwethaf: 17/03/2021
- 09/01/22
- Mepolizumab (Nucala®) for chronic eosinophilic pneumonia (OW15)
-
-
-
Dyddiad adolygu diwethaf: 17/03/2021
- 09/01/22
- Bevacizumab for ovarian cancer (OW01)
-
-
-
Dyddiad adolygu diwethaf: 29/09/2021
- 09/01/22
- Denosumab (Prolia®) for osteoporosis in men (OW07)
-
-
-
Dyddiad adolygu diwethaf: 11/11/2020
- 09/01/22
- Bendamustine and rituximab for indolent lymphomas (OW08)
-
-
-
Dyddiad adolygu diwethaf: 29/09/2021
- 09/01/22
- Bendamustine and rituximab for mantle cell lymphoma (OW09)
-
-
-
Dyddiad adolygu diwethaf: 29/09/2021
- 09/01/22
- Arsenic trioxide for high risk acute promyelocytic leukaemia (OW06)
-
-
-
Dyddiad adolygu diwethaf: 26/07/2021
- 09/01/22
- Adalimumab for paediatric intermediate, posterior and pan-uveitis (OW04)
-
-
-
Dyddiad adolygu diwethaf: 26/07/2021